In summary, clinical samples from PCa patients containing PET-CT information further confirm the role of TMEM105 in regulating PCa progression and disulfidptosis through the β-catenin-c-MYC-GLUT1 pathway. The gene discussed is SLC2A1; the disease is posterior cortical atrophy.